No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home Investing

Procter & Gamble falls short of sales estimates: Is it still a strong long-term investment?

by
July 30, 2024
in Investing
0
Procter & Gamble falls short of sales estimates: Is it still a strong long-term investment?

Procter & Gamble Co (NYSE: PG), the household staple known for its broad range of consumer goods, reported weaker-than-expected sales for the fourth quarter on Tuesday. 

Despite this, experts suggest the stock remains a strong long-term investment. 

Will McGough, Director of Investments at Prime Capital, advised investors to adopt a long-term perspective on P&G shares and not be overly concerned about the recent earnings miss.

For the quarter, P&G’s adjusted per-share earnings came in at $1.40, exceeding Street estimates by 3 cents. 

However, the company’s sales fell short of expectations, which has led to some uncertainty among investors. Full details of P&G’s earnings can be found here.

P&G CEO Jon Moeller remains positive

Despite facing ongoing challenges in China, P&G CEO Jon Moeller expressed optimism about the company’s performance. 

During an interview with CNBC, Moeller pointed out that while the Chinese market remains weak, P&G has seen strong unit volumes in Europe and the United States. He anticipates improvements in China over the medium to long term.

The company’s performance in Europe and North America has contributed to a significant boost in its gross margin, which increased by 350 basis points in fiscal 2024—marking the highest gross margin in 17 years. 

P&G also announced plans for a 10% increase in dividend payments for fiscal 2025, reflecting its robust financial health and commitment to returning value to shareholders. 

With a dividend history extending over 134 consecutive years and 68 consecutive years of increases, P&G’s track record remains unmatched by most S&P 500 companies.

Sarat Sethi recommends caution in buying P&G stock

Despite P&G’s strong fundamentals and historical dividend performance, not all analysts are enthusiastic about the stock at current levels. 

Sarat Sethi of Douglas C. Lane & Associates recommended caution, advising against new investments in P&G due to concerns over the company’s revenue growth and the challenges in the Chinese market.

“If I owned it, I wouldn’t sell it. But I wouldn’t put new money in,” Sethi told CNBC. 

He suggested that investors wait for a potential pullback before considering new investments in the stock. 

With P&G’s share price down approximately 6% in premarket trading following the earnings report, Sethi might reconsider his position as the stock could present a buying opportunity.

Currently, Wall Street analysts have a positive outlook on P&G, with an average price target of $176 per share. 

This represents a potential upside of about 10% from current levels, indicating that, despite short-term challenges, there is still room for growth in the stock.

While Procter & Gamble’s recent earnings report showed some weaknesses, the company’s strong dividend history, improved margins, and positive outlook from Wall Street suggest it remains a compelling long-term investment. 

Investors should weigh the potential for short-term volatility against the company’s solid fundamentals and historical performance when making investment decisions.

The post Procter & Gamble falls short of sales estimates: Is it still a strong long-term investment? appeared first on Invezz

Previous Post

Bill Ackman aims for $2 billion in Pershing Square IPO, scaling back from initial $25 billion target

Next Post

White House website praises lifetime Supreme Court appointments as Biden pushes term limits

Next Post
White House website praises lifetime Supreme Court appointments as Biden pushes term limits

White House website praises lifetime Supreme Court appointments as Biden pushes term limits

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
5 terrifying flashpoints that could ignite global war

5 terrifying flashpoints that could ignite global war

0
TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

0
Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

0
In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

0
5 terrifying flashpoints that could ignite global war

5 terrifying flashpoints that could ignite global war

June 9, 2025
Tesla stock sinks as Musk and Trump ridicule each other

Tesla stock sinks as Musk and Trump ridicule each other

June 8, 2025
Trump ally stands firm against ‘big, beautiful bill’ despite pressure: ‘It’ll completely backfire’

Trump ally stands firm against ‘big, beautiful bill’ despite pressure: ‘It’ll completely backfire’

June 8, 2025
Obama WH physician says Biden doc should have performed cognitive test

Obama WH physician says Biden doc should have performed cognitive test

June 8, 2025

Recent News

5 terrifying flashpoints that could ignite global war

5 terrifying flashpoints that could ignite global war

June 9, 2025
Tesla stock sinks as Musk and Trump ridicule each other

Tesla stock sinks as Musk and Trump ridicule each other

June 8, 2025
Trump ally stands firm against ‘big, beautiful bill’ despite pressure: ‘It’ll completely backfire’

Trump ally stands firm against ‘big, beautiful bill’ despite pressure: ‘It’ll completely backfire’

June 8, 2025
Obama WH physician says Biden doc should have performed cognitive test

Obama WH physician says Biden doc should have performed cognitive test

June 8, 2025

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.